Cell therapy (CT) is the process of transplanting human cells to replace or repair damaged tissue or cells. Various methods can be used to carry out cell therapy. For instance, hematopoietic stem cell transplantation, also known as bone marrow transplant, is the most widely used cell therapy. It is used to treat a variety of blood cancers and blood-related conditions.
Cell therapy market is expected to grow due to factors such as increasing the biotechnology industry, rising healthcare expenditure, growing incidences of chronic diseases, and others. The market is expected to have growth opportunities in the emerging region as they are developing their genetic sectors rapidly.This is effective in treating conditions like thalassemia, a blood disease caused by a genetic mutation. By replacing this genetic mutation with a functional gene, gene therapy treats the condition and enables the patient to make functional blood cells.
The "Global Cell Therapy Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of cell therapy market with detailed market segmentation by therapy type, product, technology, application, end user, and geography. The global cell therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cell therapy market players and offers key trends and opportunities in the market.
The global cell therapy market is segmented on the basis of therapy type, product, technology, application, end user. Based on the therapy type the market is classified as autologous, and allogeneic. Based on product the market is segmented as equipment, consumables, software and services. Based on technology the market is segmented as somatic cell technology, cell immortalization technology, viral vector technology, genome editing technology, cell plasticity technology, and three-dimensional technology. Based on application the market is classified as oncology, cardiology, orthopedic, wound management and others. And based on end user the market is divided into hospitals, regenerative medicine centers, and research institutes.
Most Promising Companies Covered as:
1. Kolon TissueGene, Inc.
3. JCR Pharmaceuticals Co. Ltd.
4. Stemedica Cell Technologies, Inc.
5. Osiris Therapeutics, Inc.
6. NuVasive, Inc.
7. Fibrocell Science, Inc.
8. Vericel Corporation
9. Cells for Cells
10. Celgene Corporation